Oncocross Co., Ltd. (KOSDAQ:382150)
12,790
-1,080 (-7.79%)
At close: Dec 5, 2025
Oncocross Market Cap
Oncocross has a market cap or net worth of 153.71 billion as of December 5, 2025.
Market Cap
153.71B
Enterprise Value
132.02B
Revenue
884.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
12,790.00
Market Cap Chart
Since December 18, 2024, Oncocross's market cap has increased from 106.25B to 153.71B, an increase of 44.67%. That is a compound annual growth rate of 46.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 153.71B | 104.46% |
| Dec 30, 2024 | 75.18B | -29.24% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.57T |
| Celltrion | 40.11T |
| ALTEOGEN | 27.92T |
| ABL Bio | 11.08T |
| SK Biopharmaceuticals | 10.61T |
| Yuhan | 8,911.91B |
| LigaChem Biosciences | 6,906.05B |
| Peptron | 6,668.76B |